
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …

UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …

Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
Doctors and hospitals received nearly $6.5 billion in research and speaking fees as well as other goods or services from …

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …

Leading UK oncologists have written an article in the May issue of The Lancet, strongly urging Britain to remain in …

Sanofi has reinforced its collaboration with Stevenage Bioscience Catalyst with the opening of a new partnering office. This office will …

The US Senate Aging Committee has announced the issuing of a subpoena to the outgoing CEO of Valeant Pharmaceuticals, Michael …

Indian regulators are set to ban an additional 1,200 fixed-dose combinations, sent for probe by Drug Controller General of India …

Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …